34272-40-7

Basic information

• Product Name: (S)-2-ETHYLPIPERIDINE
• Synonyms: (S)-2-ETHYLPIPERIDINE;(S)-2-ETHYLPIPERIDINE-HCL
• CAS NO: 34272-40-7
• Molecular Formula: C₇H₁₅N
• Molecular Weight: 113.2
• Mol File: 34272-40-7.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: (S)-2-ETHYLPIPERIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-2-ETHYLPIPERIDINE(34272-40-7)
• EPA Substance Registry System: (S)-2-ETHYLPIPERIDINE(34272-40-7)

Safety Data

• Hazardous Substances Data: 34272-40-7(Hazardous Substances Data)

Usage

General Description

(S)-2-Ethylpiperidine is a chemical compound characterized by a piperidine ring with an ethyl substituent attached to the second carbon atom. It is used as a building block in the synthesis of various pharmaceuticals and organic compounds due to its versatile reactivity. (S)-2-Ethylpiperidine is also utilized in the production of agrochemicals, dyes, and perfumes. As a liquid with a faint amine odor, it is important to handle (S)-2-Ethylpiperidine with proper care and in accordance with safety protocols to prevent any potential hazards associated with its use.

Upstream product

• 1484-80-6 2-ethylpiperidine 
• 1643770-97-1 (S)-2,2-dimethyl-5-oxo-3-(2-phenylacetyl)imidazolidin-1-yl 2-methoxy-2-phenylacetate 

Downstream Products

• 247934-45-8 2(S)-ethyl 1-[(1-phenyl 3-isoquinolyl) carbonyl]piperidine 
• 558479-15-5 (2S)-ethyl-1-[(R)-oxiranylmethyl] piperidine 

Relevant articles and documents

Stereoelectronic basis for the kinetic resolution of n-heterocycles with chiral acylating reagents

The kinetic resolution of N-heterocycles with chiral acylating agents reveals a previously unrecognized stereoelectronic effect in amine acylation. Combined with a new achiral hydroxamate, this effect makes possible the resolution of various N-heterocycles by using easily prepared reagents. A transition-state model to rationalize the stereochemical outcome of this kinetic resolution is also proposed.

THERAPEUTIC COMBINATIONS COMPRISING A SELECTIVE ESTROGEN RECEPTOR MODULATOR AND A SELECTIVE ANDROGEN RECEPTOR MODULATOR

This invention relates to a pharmaceutical combination of a selective estrogen receptor modulator (SERM) and a selective androgen receptor modulator (SARM). Particularly, this invention relates to a pharmaceutical composition comprising cis-6-phenyl-5-(4-(2-pyrrolidin-1-yl-ethoxy)-phenyl)-5,6,7,8-tetrahydronapthalene-2-ol, or a pharmaceutically acceptable salt thereof; and a selective androgen receptor modulator. This invention also relates to methods of treatment using the pharmaceutical composition comprising cis-6-phenyl-5-(4-(2-pyrrolidin-1-yl-ethoxy)-phenyl)-5,6,7,8-tetrahydronapthalene-2-ol, or a pharmaceutically acceptable salt thereof; and a selective androgen receptor modulator. Particularly, this invention is directed to methods to prevent and/or restore age-related decline in muscle mass and strength, treat a wasting disease, treat a condition that prevents with low bone mass, increase muscle mass, increase lean body mass, decrease fat body mass, treat bone fracture and muscle damage and treat female sexual dysfunction in mammals, including humans.